Estradiol Dynamics in Assisted Reproductive Technologies

Estradiol, a key oestrogenic steroid, orchestrates follicular maturation, endometrial proliferation and embryo implantation in assisted reproductive technologies (ART). During controlled ovarian stimulation, serum estradiol levels rise in response to exogenous gonadotrophins, serving as a surrogate for follicle count and granulosa cell activity. In fresh in vitro fertilisation (IVF) cycles, supraphysiological estradiol may alter endometrial receptivity by modulating gene expression and vascular development, while in frozen embryo transfer (FET) protocols, exogenous estradiol is administered to synchronise endometrial transformation for thawed embryo implantation. Optimal estradiol dynamics balance follicular yield with a receptive endometrium, yet consensus on ideal concentration thresholds remains elusive. Recent work has refined our understanding of timing and magnitude of estradiol exposure, highlighting its differential impact on cleavage-stage versus blastocyst transfers, and informing personalised hormone replacement regimens. Ongoing research aims to delineate safe upper limits, integrate non-invasive monitoring and develop predictive models for estradiol-mediated implantation success.

Research from Nature Portfolio

Recent studies have examined the influence of pre-transfer estradiol concentrations in hormone-replacement FET cycles. In hormone replacement regimens, patients with quartile-based serum estradiol ranging from low to high on the endometrial transformation day exhibited comparable implantation and pregnancy rates, indicating that within a broad physiological window, variation in pre-transfer oestrogen may not affect clinical outcomes. Investigations into embryo stage have shown that elevated estradiol on the day of progesterone initiation exerts a negative effect on implantation and live birth in cleavage-stage transfers, whereas blastocyst transfers remain unaffected, suggesting embryo developmental stage modulates endometrial sensitivity to oestrogen. These findings support tailored oestradiol supplementation strategies according to embryo stage and underline the resilience of blastocyst-stage transfer protocols to hormonal fluctuations.

Estradiol Dynamics in Assisted Reproductive Technologies publication trend

The graph below shows the total number of articles in estradiol dynamics in assisted reproductive technologies across all publications each year (not limited to Nature Index journals).

Technical terms

Estradiol: The predominant oestrogen hormone during reproductive years, driving follicle growth and endometrial proliferation.

Controlled ovarian stimulation (COS): Use of exogenous gonadotrophins to induce the development of multiple ovarian follicles for IVF.

Freeze-all strategy: An ART approach in which all embryos are cryopreserved after retrieval, delaying transfer to a subsequent cycle.

Frozen embryo transfer (FET): The procedure of thawing and transferring embryos in hormonally prepared or natural endometrial cycles.

Endometrial receptivity: The state of the uterine lining when optimally prepared for embryo implantation, influenced by hormonal milieu and gene expression.

References

1. Effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles. Scientific Reports (2023).
2. Elevated estradiol levels in frozen embryo transfer have different effects on pregnancy outcomes depending on the stage of transferred embryos. Scientific Reports (2022).
3. The effect of peak serum estradiol level during ovarian stimulation on cumulative live birth and obstetric outcomes in freeze-all cycles. Frontiers in Endocrinology (2023).
4. The relationship between serum oestrogen levels and clinical outcomes of hormone replacement therapy-frozen embryo transfer: a retrospective clinical study. BMC Pregnancy and Childbirth (2022).